Effects of HIV-1 Tat protein on ion secretion and on cell proliferation in human intestinal epithelial cells

Gastroenterology

Volumn 124, Issue 2, 2003, Pages 368-376

  Canani, Roberto Berni ^a   Cirillo, Pia ^a   Mallardo, Giuseppe ^a   Buccigrossi, Vittoria ^a   Secondo, Agnese ^a   Annunziato, Lucio ^a   Bruzzese, Eugenia ^a   Albano, Fabio ^a   Selvaggi, Francesco ^b   Guarino, Alfredo ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL L TYPE; ENTEROTOXIN; PROTEIN ANTIBODY; TRANSACTIVATOR PROTEIN; VIRUS PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CALCIUM CELL LEVEL; CELL DAMAGE; CELL INTERACTION; CELL PROLIFERATION; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; ELECTRIC RESISTANCE; ENTEROPATHY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTESTINE EPITHELIUM CELL; INTESTINE MUCOSA; ION TRANSPORT; MICROFLUOROMETRY; PRIORITY JOURNAL;

EID: 0037308371     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2003.50056     Document Type: Article

References (37)

1. Sharpstone D, Gazzard B. Gastrointestinal manifestations of HIV infection. Lancet 1996;348:379-383.
2. Seidman EG, Russo P. Gastrointestinal manifestations of human immunodeficiency virus infection and other secondary immunodeficiencies. In: Allan Walker W, ed. Pediatric gastrointestinal disease: pathophysiology, diagnosis, management. Volume 1. 3rd ed. Ontario: Decker, 2000:548-568.
3. Kotler DP, Gaetz H, Lange M, Klein EB, Holt PR. Enteropathy associated with the acquired immunodeficiency syndrome. Ann Intern Med 1984;101:421-428.
4. Janoff EN, Smith PD. Emerging concepts in gastrointestinal aspects of HIV-1 pathogenesis and management. Gastroenterology 2001;120:607-621.
5. Rubartelli A, Poggi A, Sitia R, Zocchi MR. HIV-1 Tat: a polypeptide for all seasons. Trends Immunol Today 1998;19:543-545.
6. Delezay, Yahi N, Tamalet C, Baghdguian S, Boudier JA, Fantini J. Direct effect of type 1 human immunodeficiency virus on intestinal epithelial cell differentiation: relationship to HIV-1 enteropathy. Virology 1997;238:231-242.
7. Kotler DP. Characterization of intestinal disease associated with human immunodeficiency virus infection and response to antiretroviral therapy. J Infect Dis 1999;179(Suppl 3):S454-S456.
8. Dong Y, Zeng CQY, Ball JM, Estes M, Morris AP. The rotavirus enterotoxin NSP4 mobilizes intracellular calcium in human intestinal cells by stimulating phospholipase C-mediated inositol 1,4,5-trisphosphate production. Proc Natl Acad Sci U S A 1999;94:3960-3965.
9. Morris AP, Estes MK. Microbes and microbial toxins: paradigms for microbial-mucosal interactions. VIII. Pathological consequences of rotavirus infection and its enterotoxin. Am J Physiol 2001;281:G303-G310.
10. Gallo RC. Tat as one key to HIV-induced immune pathogenesis and Pat toxoid as an important component of a vaccine. Proc Natl Acad Sci U S A 1999;96:8324-8326.
11. Zocchi MR, Rubartelli A, Morgavi P, Poggi A. HIV-1 Tat inhibits human natural killer cell function by blocking L-type calcium channels. J Immunol 1998;161:2938-2943.
12. Haughey NJ, Golden CP, Nath A, Geiger JD. Involvement of inositol 1,4,5-trisphosphate-regulated stores of intracellular calcium in calcium dysregulation and neuron cell death caused by HIV-1 protein Tat. J Neurochem 1999;73:1363-1374.
13. Berni Canani R, Bisceglia M, Bruzzese E, Mallardo G, Guarino A. Growth hormone stimulates, through tyrosine kinase ion transport and proliferation in human intestinal cells. J Pediatr Gastroenterol Nutr 1999;28:315-320.
14. Guarino A, Bisceglia M, Berni Canani R, Boccia MC, Mallardo G, Bruzzese E, Massari P, Rappuoli R, Telford J. Enterotoxic effect of the vacuolating toxin produced by Helicobacter pylori in Caco-2 cells. J Infect Dis 1998;178:1373-1378.
15. - fluxes and short-circuit current. Am J Physiol 1971;220:1388-1398.
16. Guarino A, Berni Canani R, Pozio E, Terracciano L, Albano F, Mazzeo M. Enterotoxic effect of stool supernatant of Cryptosporidium infected calves on human jejunum. Gastroenterology 1994;106:28-34.
17. Albano F, Thompson MR, Orrù S, Scaloni A, Musetta A, Pucci P, Guarino A. Structural and functional features of modified heatstable toxins produced by enteropathogenic Klebsiella cells. Pediatr Res 2000;48:685-690.
18. 3 cells. Mol Pharmacol 2000;58:1115-1128.
19. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985;260:3440-3450.
20. Guarino A, Casola A, Bruzzese E, Saini M, Nitsch L, Rubino A. Human serum immunoglobulin counteracts rotaviral infection in Caco-2 cells. Pediatr Res 1996;40:881-887.
21. Fasano A. Cellular microbiology: how enteric pathogens socialize with their intestinal host. J Pediatr Gastroenterol Nutr 1998;26:520-532.
22. O'Farrel M, Ziogas J, Marley PD. Effects of N-and L-type calcium channel antagonists and Bay K8644 on nerve-induced catecholamine secretion from bovine perfused adrenal glands. Br J Pharmacol 1997;121:381-388.
23. Albini A. The angiogenesis induced by HIV-1 TAT protein is mediated by the flk-1/KDR receptor on vascular endothelial cells. Nat Med 1996;2:1371-1375.
24. Deplancke B, Gaskins HR. Microbial modulation of innate defense: goblet cells and intestinal mucus layer. Am J Clin Nutr 2001;73:1131S-11141S.
25. Ouellette AJ, Bevins CL. Paneth cell defensins and innate immunity of the small bowel. Inflamm Bowel Dis 2001;7:43-50.
26. Winter H. Gastrointestinal tract function and malnutrition in HIV-infected children. J Nutr 1996;126:2620S-2622S.
27. Lu SS. Pathophysiology of HIV-associated diarrhea. Gastroenterol Clin North Am 1997;26:175-189.
28. Bartlett JG, Belitsos PC, Sears CL. AIDS enteropathy. Clin Infect Dis 1992;15:726-735.
29. Scheidegger P, Weiglhofer W, Suarez S, Console S, Waltenberger J, Pepper MS, Jaussi E, Ballmer-Hofer K. Signalling properties of an HIV-encoded angiogenic peptide mimicking vascular endothelial growth factor activity. Biochem J 2001;353:569-578.
30. Siafakas CG, Anatolitou F, Fusunyan RD, Allan Walker W, Sanderson IR. Vascular endothelial growth factor (VEGF) is present in human breast milk and its receptor is present on intestinal epithelial cells. Pediatr Res 1999;45:652-657.
31. Kelly EJ, Naik S, Sanderson IR. VEGF signals through the MAP kinase pathway in intestinal epithelial cells. J Pediatr Gastroenterol Nutr 2000;31:S74.
32. Poggi A, Rubartelli A, Zocchi MR. Involvement of dihydropyridine-sensitive calcium channels in human dendritic cell function. Competition by HIV-1 Tat. J Biol Chem 1998;273:7205-7209.
33. The Italian Paediatric Intestinal/HIV Study Group. Intestinal malabsorption of HIV- infected children: relationship to diarrhoea, failure to thrive, enteric micro-organisms and immune impairment. AIDS 1993;7:1435-1440.
34. Berni Canani R, Spagnuolo MI, Cirillo P, Guarino A. Ritonavir combination therapy restores intestinal function in children with advanced human immunodeficiency virus disease. J Acquir Immune Defic Syndr Hum Retrovirol 1999;21:307-312.
35. Foundraine NA. Improvement of chronic diarrhoea in patients with advanced HIV-1 infection during potent antiretroviral therapy. AIDS 1998;12:35-41.
36. Le Buanec H, Bizzini B. Procedures for preparing biologically inactive, but immunogenic HIV-1 Tat protein (Tat toxoid) for human use. Biomed Pharmacother 2000;54:41-44.
37. Ensoli B, Cafaro A. Control of viral replication and disease onset in cynomolgus monkeys by HIV-1 Tat vaccine. J Biol Regul Homeost Agents 2000;14:22-26.